caspofungin teva 70 mg powder for concentrate for solution for infusion
teva b.v. - caspofungin acetate - pdr/conc/soln for infus - 70 milligram(s) - other antimycotics for systemic use; caspofungin
oxaliplatin 5 mg/ml concentrate for soln for inf
generics (uk) limited - oxaliplatin - concentrate for soln for inf - 5 mg/ml - platinum compounds
fultium-d3
internis pharmaceuticals limited - colecalciferol - oral drops solution - 250 - colecalciferol
pemetrexed genthon 25 mg/ml concentrate for solution for infusion
genthon b.v. - pemetrexed - concentrate for solution for infusion - 25 milligram(s)/millilitre - folic acid analogues; pemetrexed
tisseel ready to use solution for sealant (10ml vial)
baxter healthcare limited - human fibrinogen; aprotinin; human thrombin; calcium chloride dihydrate - solution for sealant - human fibrinogen 455 mg; aprotinin 1500 kiu/ml; human thrombin 2500 iu; calcium chloride dihydrate 200 mmol - antihemorrhagics
tisseel ready to use solution for sealant (4ml vial)
baxter healthcare limited - human fibrinogen; aprotinin; human thrombin; calcium chloride dihydrate - solution for sealant - human fibrinogen 182 mg; aprotinin 6000 kiu/ml; human thrombin 1000 iu; calcium chloride dihydrate 80 µmol - antihemorrhagics
azelastine xanthis nasal spray solution 1mg/ml
xantis pharma limited lemesou, 5 eurosure tower, 1st floor, flat/office 101, 2112, nicosia, cyprus - azelastine hydrochloride - nasal spray, solution - azelastine hydrochloride 0.14 mg - nasal preparations
gemcitabine 100mg/ml concentrate for solution for infusion
accord healthcare limited - gemcitabine - concentrate for solution for infusion - gemcitabine 1000 mg - antineoplastic agents
gemcitabine 100mg/ml concentrate for solution for infusion
accord healthcare limited - gemcitabine - concentrate for solution for infusion - gemcitabine 1500 mg - antineoplastic agents
gemcitabine 100mg/ml concentrate for solution for infusion
accord healthcare limited - gemcitabine - concentrate for solution for infusion - gemcitabine 2000 mg - antineoplastic agents